Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis - Wikidata - awgldk - TriplyDB

Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis

Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis

http://www.wikidata.org/entity/Q36893921

about

Gut Microbiota and Complications of Liver Disease.Developmental origins of NAFLD: a womb with a clue.Population Pharmacokinetics of Morphine in Patients With Nonalcoholic Steatohepatitis (NASH) and Healthy Adults.Key Role for the 12-Hydroxy Group in the Negative Ion Fragmentation of Unconjugated C24 Bile Acids.Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease.Non-alcoholic fatty liver disease and diabetes.Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.Liver Cholesterol Overload Aggravates Obstructive Cholestasis by Inducing Oxidative Stress and Premature Death in Mice Metabonomics Research Progress on Liver Diseases.The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids.Nuclear receptors and nonalcoholic fatty liver disease.Effect of Liver Disease on Hepatic Transporter Expression and Function.Circadian clock control of hepatic lipid metabolism: role of small heterodimer partner (Shp).The Contributing Role of Bile Acids to Metabolic Improvements After Obesity and Metabolic Surgery.Elevated cholesterol levels have a poor prognosis in a cholestasis scenario.Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review.Intestinal microbiota and nonalcoholic steatohepatitis.The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification.Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice.Characterization of the Cytochrome P450 epoxyeicosanoid pathway in non-alcoholic steatohepatitis.Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.Urinary metabolic insights into host-gut microbial interactions in healthy and IBD children.Investigation of Liver Injury of Polygonum multiflorum Thunb. in Rats by Metabolomics and Traditional Approaches.Construction of multiple linear regression models using blood biomarkers for selecting against abdominal fat traits in broilers.Reciprocal interactions between bile acids and gut microbiota in human liver diseases.Organic Solute Transporter OSTα/ß is Over-Expressed in Nonalcoholic Steatohepatitis and Modulated by Drugs Associated with Liver Injury.Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans.Engineered FGF19 eliminates bile acid toxicity and lipotoxicity leading to resolution of steatohepatitis and fibrosis in mice.Detection technologies and metabolic profiling of bile acids: a comprehensive review.Analogy between non-alcoholic steatohepatitis (NASH) and hypertension: a stepwise patient-tailored approach for NASH treatment.Can BSEP Inhibition Testing In Drug Discovery And Development Reduce Liver Injury Risk? - An International Transporter Consortium Perspective Bile Acids as Potential Biomarkers to Assess Liver Impairment in Polycystic Kidney Disease Obesity diabetes and the role of bile acids in metabolism

P2860

Q30236024-D35D1310-BC5B-41FD-AB31-C130832E7E16 Q30241940-A6E0C254-1D94-448D-93C2-FEA87C5F4CF3 Q33729768-AC3530A9-5CC6-4E5B-87E6-B7DE123930D9 Q33906607-AC7FF112-AFA5-4388-849E-7AE954C9B41B Q36023779-14609D79-0274-406C-820B-5A76ECE00E86 Q37091659-DD19EB2A-DB88-48B8-8656-9B68642D2E33 Q37139504-2AAABAF6-BBF3-468B-AED1-92E29477877F Q37231732-3CBD3218-DB28-4699-A546-744C75EE654C Q37683642-F420680B-FF4F-417C-A09F-C18BC882BC59 Q38659340-F5D1B850-C93F-4298-B4EC-2B661E833859 Q38768048-DBB2E65E-D49C-4E3C-AA6C-E25A4BA28093 Q38808182-EDBFE30E-973F-4A15-A253-876D3F66ED26 Q38912884-AC787AB0-7C3E-4FDD-8786-FAB0F1A9BC64 Q38913696-FD591691-B58B-4DBC-B201-B54C618519CE Q38925850-0C320766-94E5-44DE-94FA-94EDE1421E65 Q39093948-00F5668D-3671-437F-955C-F73680F712CA Q39160020-285572D5-79AD-40CD-96F8-E4D0A8372350 Q39262148-132D299D-8BEB-4877-A0BA-94EF3B071C2E Q39363389-B0491F57-7C06-451E-83F6-F2FF69070DFB Q41094296-29025D6D-E213-4C29-9030-35763C94DA44 Q41172019-CE2183E7-F24E-43A6-A0AD-14A326570C07 Q42000430-8CB55496-B5BF-40CE-BAB3-0563692A53C3 Q42237462-542E8763-9DAB-4D03-BEA9-802FC7585F3E Q46619819-7B19D3E9-0D1C-42E6-BC73-A3A2DB6BBD41 Q47221781-4A85561A-9FB1-4251-9F87-8FEA2205C4B5 Q47389652-AECFF352-6BD9-4941-9187-E62FA2A7FF45 Q50116444-0B466554-EBDB-4FA7-BF5C-74BB04F8B807 Q52669418-1F192B9B-A759-48DB-A359-647CE5ED1159 Q52699090-4C18E89A-FA1A-4E23-9BF2-3E022F567A25 Q55065719-084214A9-148D-4A99-8F71-4922E0096D78 Q55323878-8961B51F-5D41-48E9-99CF-ECB6D981413D Q57111135-16281FD7-8B96-4A51-A860-1480412449F5 Q57121976-7BE5AB31-D861-4FBA-8BFA-E59308C554CF Q57136131-ECB45A60-8DCC-43B2-8FF9-56AD0BAD9678

P2860

Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis

http://www.wikidata.org/entity/Q36893921

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis

@en

type

label

Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis

@en

prefLabel

Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis

@en

P1433

Q36893921-3D719501-CB2F-46BC-ACBA-135ACF89B18F

P1476

Q36893921-2583D0BC-1787-46C5-830F-C276B7969433

P2093

Q36893921-049B66FD-4169-4108-BB62-09FE9626C869

Q36893921-08DB0443-0AE7-4076-B5F2-2B45FE6067F0

Q36893921-39C5C698-03EF-4C48-8816-E45F04F28516

Q36893921-7B816DC6-BE01-414A-882F-A9FE82AE4859

Q36893921-E365802A-2EE0-461B-A9C4-7DE235548039

Q36893921-EE071F69-F8DE-4E7F-8279-636E7636E436

P2860

Q36893921-00362614-2407-4DA5-813A-8350D20E4378

Q36893921-014FD58F-7A87-4672-92F6-6E26BC6BDC6A

Q36893921-1632B1E5-DA8F-4528-A92C-8414D1EC414E

Q36893921-1AC6BDB5-D13A-473A-BE50-0BA2EFAA2FC9

Q36893921-20E12A05-15CE-48F3-9B3A-3475BAB6936C

Q36893921-2961D58F-CA4C-412B-B904-276A5B3BC328

Q36893921-2D8724A6-726B-4899-A32F-70867B48F875

Q36893921-2E746219-92E3-4857-BFE8-A8AE807073EA

Q36893921-470D2546-F949-4B93-BB4F-984A2B1C8A1E

Q36893921-67096CA0-1886-4962-B948-3E4C8025821D

P2888

Q36893921-4A1D624B-B519-4518-B454-672C5CE929F1

P304

Q36893921-BE836782-4636-4C65-B758-B6ADCB0C8709

P31

Q36893921-230F83F3-9A88-44AA-A9EF-A2DDC5D2B977

P356

Q36893921-8C72E1ED-C07C-4C3E-8304-5730240D0776

P433

Q36893921-A214CA11-1B3D-4EF1-8EE9-0E22D5021015

P478

Q36893921-88FAE284-19D0-4761-88B8-ABC4E25AC948

P50

Q36893921-029AEE2E-FA83-4355-A2D4-B424F513A370

Q36893921-2C1E4D9D-4C7F-4FE8-9CE4-0C906479F450

P577

Q36893921-CD1694F4-03A7-4DB2-9992-9157EF1E3F1A

P698

Q36893921-28D8B94E-854B-465F-9E7E-7097B6885A55

P921

Q36893921-C8ED11C1-FB8D-45FF-BBE2-C74C10604FC8

P932

Q36893921-7833C3A9-9A91-4597-96E7-44CBD1AA94A4

P356

S10620-015-3776-8

P1433

Digestive Diseases and Sciences

P1476

Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis

@en

P2093

A Sidney Barritt

http://www.w3.org/2001/XMLSchema#string

Brian C Ferslew

http://www.w3.org/2001/XMLSchema#string

Curtis K Johnston

http://www.w3.org/2001/XMLSchema#string

Guoxiang Xie

http://www.w3.org/2001/XMLSchema#string

Mingming Su

http://www.w3.org/2001/XMLSchema#string

Paul W Stewart

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace

Alcoholic and non-alcoholic steatohepatitis

The enzymes, regulation, and genetics of bile acid synthesis

Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies

Obesity and the risk of gallbladder cancer: a meta-analysis

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production

Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

P2888

s10620-015-3776-8

P304

3318-3328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10620-015-3776-8

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26138654

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

P932

4864493

http://www.w3.org/2001/XMLSchema#string